Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
4.18M
-
Shares change
-
-2.04M
-
Total reported value, excl. options
-
$3.97M
-
Value change
-
-$1.94M
-
Put/Call ratio
-
0.31
-
Number of buys
-
4
-
Number of sells
-
-14
-
Price
-
$0.95
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q1 2022
32 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q1 2022.
IGC Pharma, Inc. - COM NEW (IGC) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.18M shares
.
Largest 10 shareholders include Mirae Asset Global Investments Co., Ltd. (1.38M shares), BlackRock Inc. (859K shares), VANGUARD GROUP INC (646K shares), GEODE CAPITAL MANAGEMENT, LLC (292K shares), STATE STREET CORP (179K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (139K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (120K shares), Vident Investment Advisory, LLC (104K shares), Davy Global Fund Management Ltd (97.2K shares), and DEARBORN PARTNERS LLC (96.9K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.